BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 7173482)

  • 21. Hormonal placental functions and intrauterine growth retardation in patients with positive contraction stress tests.
    Odendaal HJ; Malan C; Oosthuizen J
    S Afr Med J; 1981 May; 59(23):822-4. PubMed ID: 7233299
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Correlation between human placental lactogen levels and glucose metabolism in pregnant women with intrauterine growth retardation.
    Bagga R; Vasishta K; Majumdar S; Garg SK
    Aust N Z J Obstet Gynaecol; 1990 Nov; 30(4):310-3. PubMed ID: 2082885
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Human placental lactogen serum levels in venous and capillary blood from women in late pregnancy.
    Axelsson O; Malmström H
    Gynecol Obstet Invest; 1983; 15(1):19-25. PubMed ID: 6822371
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Placental perfusion, endocrine parameters of pregnancy and cardiotocographic non-stress tests in cases of intrauterine retardation].
    Doszpod J; Török M; Prievara F; Csákány MG; Gáti I
    Zentralbl Gynakol; 1984; 106(21):1413-8. PubMed ID: 6516633
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Maternal serum HPL levels in normal and complicated pregnancy as an index of placental function.
    Ylikorkala O
    Acta Obstet Gynecol Scand Suppl; 1973; 26():1-52. PubMed ID: 4522254
    [No Abstract]   [Full Text] [Related]  

  • 26. Maternal serum concentrations of human placental lactogen, estradiol and pregnancy specific beta 1-glycoprotein and fetal growth retardation.
    Gardner MO; Goldenberg RL; Cliver SP; Boots LR; Hoffman HJ
    Acta Obstet Gynecol Scand Suppl; 1997; 165():56-8. PubMed ID: 9219458
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Elevated levels of b-human chorionic gonadotropin and human placental lactogen between 11-13 weeks' gestation and subsequent pregnancy complications in Omani women.
    Krolikowski A; Al Busaidi F; Al Wahaibi A
    Saudi Med J; 2004 Mar; 25(3):382-4. PubMed ID: 15048184
    [No Abstract]   [Full Text] [Related]  

  • 28. Tests of fetal wellbeing in the third trimester of pregnancy.
    Hughes G; Bischof P; Wilson G; Smith R; Klopper A
    Br J Obstet Gynaecol; 1980 Aug; 87(8):650-6. PubMed ID: 6158994
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Serum levels of oestriol and human placental lactogen.
    Llewellyn-Jones JD
    Med J Aust; 1979 Dec; 2(13):700-1. PubMed ID: 530205
    [No Abstract]   [Full Text] [Related]  

  • 30. Endocrine evaluation in the diagnosis of intrauterine growth retardation.
    Tulchinsky D
    Clin Obstet Gynecol; 1977 Dec; 20(4):969-77. PubMed ID: 146583
    [No Abstract]   [Full Text] [Related]  

  • 31. Human placental lactogen in late pregnancy.
    Lancet; 1978 Jun; 1(8075):1213. PubMed ID: 77982
    [No Abstract]   [Full Text] [Related]  

  • 32. Human placental lactogen and ultrasonic screening for the detection of placental insufficiency.
    Kullander S; Marsál K; Persson PH
    Contrib Gynecol Obstet; 1982; 9():129-44. PubMed ID: 6754247
    [No Abstract]   [Full Text] [Related]  

  • 33. Maternal blood levels of human placental lactogen in the prediction of fetal growth retardation: choosing a cut-off point between normal and abnormal.
    Lilford RJ; Obiekwe BC; Chard T
    Br J Obstet Gynaecol; 1983 Jun; 90(6):511-5. PubMed ID: 6860597
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Human placental lactogen in the blood in fetal growth retardation].
    Bila S; Sulović V; Genbacev O
    Srp Arh Celok Lek; 1980 Apr; 108(4):317-24. PubMed ID: 7233269
    [No Abstract]   [Full Text] [Related]  

  • 35. Oxytocinase and human placental lactogen for the prediction of intrauterine growth retardation.
    Hensleigh PA; Cheatum SG; Spellacy WN
    Am J Obstet Gynecol; 1977 Nov; 129(6):675-8. PubMed ID: 920768
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Study on blood level of human placental lactogen in abnormal pregnancy.
    Samanta B; Dutta GP
    J Indian Med Assoc; 1989 Sep; 87(9):205-7. PubMed ID: 2621369
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The use of human placental lactogen in the antepartum monitoring of pregnancy.
    Spellacy WN
    Clin Obstet Gynaecol; 1979 Aug; 6(2):245-58. PubMed ID: 498680
    [No Abstract]   [Full Text] [Related]  

  • 38. Clinical and pathologic evaluation of serum immunoreactive human placental lactogen (IR-HPL) in abnormal pregnancy.
    Varma K; Driscoll SG; Emerson K; Selenkow HA
    Obstet Gynecol; 1971 Oct; 38(4):487-99. PubMed ID: 4999733
    [No Abstract]   [Full Text] [Related]  

  • 39. Toxemia of pregnancy: assessment of fetal distress by urinary estriol and circulating human placental lactogen and alpha-fetoprotein levels.
    Garoff L; Seppälä M
    Am J Obstet Gynecol; 1976 Dec; 126(8):1027-33. PubMed ID: 63245
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Biophysical and biochemical markers at 30-34 weeks' gestation in the prediction of adverse perinatal outcome.
    Valiño N; Giunta G; Gallo DM; Akolekar R; Nicolaides KH
    Ultrasound Obstet Gynecol; 2016 Feb; 47(2):194-202. PubMed ID: 26094952
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.